Product Information
OSELTAMIVIR PHOS 45 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.8309 per EA under NDC 76282070345. Its NADAC has been published 116 times since Apr 10, 2024.
Strength
45 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282070345
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA217467On Market Since
12/1/2023
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has been published 116 times since Apr 10, 2024, and over the history we have for it it has declined 45.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8309 per EA |
|---|---|
| All-time high | $1.6220 (Dec 11, 2024) |
| All-time low | $0.8309 (Jun 17, 2026) |
| 52-week high | $1.1740 |
| 52-week low | $0.8309 |
| Median price | $1.1449 |
| Average price | $1.1634 |
| Largest weekly change | -30.3% (Apr 17, 2024) |
| Weeks tracked | 116 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the OSELTAMIVIR PHOSPHATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 45 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 45 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.8309 per EA (NDC 76282070345), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 45 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has declined 45.2%. It has been tracked across 116 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 45 MG CAPSULE?
Since Apr 10, 2024, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has ranged from a low of $0.8309 (Jun 17, 2026) to a high of $1.6220 (Dec 11, 2024), with a median of $1.1449 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 45 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OSELTAMIVIR PHOS 45 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures OSELTAMIVIR PHOS 45 MG CAPSULE?
OSELTAMIVIR PHOS 45 MG CAPSULE (NDC 76282070345) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification